TP53 and breast carcinoma: In the present study, we investigated the response of in vitro breast cancer cells to multiple therapeutic targets by silencing mutant p53 through RNA interference mechanisms and investigating the inhibitory effect of EGCG on tumor cell survival, growth, and migration, and thereby the mechanism of treatment resistance using dual targeted therapy.